These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19023042)

  • 1. Everolimus inhibits monocyte/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits.
    Baetta R; Granata A; Canavesi M; Ferri N; Arnaboldi L; Bellosta S; Pfister P; Corsini A
    J Pharmacol Exp Ther; 2009 Feb; 328(2):419-25. PubMed ID: 19023042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective clearance of macrophages in atherosclerotic plaques by autophagy.
    Verheye S; Martinet W; Kockx MM; Knaapen MW; Salu K; Timmermans JP; Ellis JT; Kilpatrick DL; De Meyer GR
    J Am Coll Cardiol; 2007 Feb; 49(6):706-15. PubMed ID: 17291937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective clearance of macrophages in atherosclerotic plaques by the protein synthesis inhibitor cycloheximide.
    Croons V; Martinet W; Herman AG; Timmermans JP; De Meyer GR
    J Pharmacol Exp Ther; 2007 Mar; 320(3):986-93. PubMed ID: 17135342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms in intimal monocyte-macrophage recruitment. A special role for monocyte chemotactic protein-1.
    Valente AJ; Rozek MM; Sprague EA; Schwartz CJ
    Circulation; 1992 Dec; 86(6 Suppl):III20-5. PubMed ID: 1424047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trapidil inhibits monocyte chemoattractant protein-1 and macrophage accumulation after balloon arterial injury in rabbits.
    Poon M; Cohen J; Siddiqui Z; Fallon JT; Taubman MB
    Lab Invest; 1999 Nov; 79(11):1369-75. PubMed ID: 10576207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia.
    Namiki M; Kawashima S; Yamashita T; Ozaki M; Hirase T; Ishida T; Inoue N; Hirata K; Matsukawa A; Morishita R; Kaneda Y; Yokoyama M
    Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):115-20. PubMed ID: 11788470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia.
    Mueller MA; Beutner F; Teupser D; Ceglarek U; Thiery J
    Atherosclerosis; 2008 May; 198(1):39-48. PubMed ID: 17980369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: inhibitory effect on monocyte chemotaxis.
    Pakala R; Stabile E; Jang GJ; Clavijo L; Waksman R
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):481-6. PubMed ID: 16160601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Everolimus, a promising medical therapy for coronary heart disease?
    Jia L; Hui RT
    Med Hypotheses; 2009 Aug; 73(2):153-5. PubMed ID: 19375241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Everolimus-induced mTOR inhibition selectively depletes macrophages in atherosclerotic plaques by autophagy.
    Martinet W; Verheye S; De Meyer GR
    Autophagy; 2007; 3(3):241-4. PubMed ID: 17224626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of rapamycin on rat macrophage viability and chemotaxis toward allogenic pancreatic islet supernates.
    Danner S; Sigrist S; Moreau F; Mandes K; Vodouhé C; Langlois A; Soskin S; Fichbach M; Pinget M; Kessler L
    Transplant Proc; 2008 Mar; 40(2):470-2. PubMed ID: 18374105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis.
    Hlawaty H; Jacob MP; Louedec L; Letourneur D; Brink C; Michel JB; Feldman L; Bäck M
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):518-24. PubMed ID: 19164806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Everolimus triggers cytokine release by macrophages: rationale for stents eluting everolimus and a glucocorticoid.
    Martinet W; Verheye S; De Meyer I; Timmermans JP; Schrijvers DM; Van Brussel I; Bult H; De Meyer GR
    Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1228-35. PubMed ID: 22345170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone inhibits macrophage accumulation after balloon arterial injury in cholesterol fed rabbits.
    Poon M; Gertz SD; Fallon JT; Wiegman P; Berman JW; Sarembock IJ; Taubman MB
    Atherosclerosis; 2001 Apr; 155(2):371-80. PubMed ID: 11254907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral everolimus inhibits neointimal proliferation in prosthetic pulmonary valved stents in pigs.
    Kuehne T; Pietzner K; Lehmkuhl HB; Gelernter D; Peters B; Krueger JJ; Meinus C; Klimes K; Brinkert F; Ewert P; Berger F
    J Heart Valve Dis; 2008 Jul; 17(4):465-72. PubMed ID: 18751477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of macrophage migration by neurotoxic prion protein fragment.
    Zhou H; Zhou X; Kouadir M; Zhang Z; Yin X; Yang L; Zhao D
    J Neurosci Methods; 2009 Jun; 181(1):1-5. PubMed ID: 19447501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The monocyte/macrophage as a therapeutic target in atherosclerosis.
    Saha P; Modarai B; Humphries J; Mattock K; Waltham M; Burnand KG; Smith A
    Curr Opin Pharmacol; 2009 Apr; 9(2):109-18. PubMed ID: 19230773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everolimus attenuates neointimal hyperplasia in cultured human saphenous vein grafts.
    Semsroth S; Stigler RG; Bernecker OY; Ruttmann-Ulmer E; Troppmair J; Macfelda K; Bonatti JO; Laufer G
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):515-20. PubMed ID: 19167904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercoagulability inhibits monocyte transendothelial migration through protease-activated receptor-1-, phospholipase-Cbeta-, phosphoinositide 3-kinase-, and nitric oxide-dependent signaling in monocytes and promotes plaque stability.
    Seehaus S; Shahzad K; Kashif M; Vinnikov IA; Schiller M; Wang H; Madhusudhan T; Eckstein V; Bierhaus A; Bea F; Blessing E; Weiler H; Frommhold D; Nawroth PP; Isermann B
    Circulation; 2009 Sep; 120(9):774-84. PubMed ID: 19687358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated cholesterol levels in the plasma membranes of macrophages inhibit migration by disrupting RhoA regulation.
    Nagao T; Qin C; Grosheva I; Maxfield FR; Pierini LM
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1596-602. PubMed ID: 17495238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.